(Chest. 1999;116:825-827.)
© 1999
American College of Chest Physicians
Endobronchial Stenting for Severe Airway Obstruction in Relapsing Polychondritis*
John L. Faul, MD;
Stephen T. Kee, MD and
Norman W. Rizk, MD, FCCP
*
From the Division of Pulmonary and Critical Care Medicine (Drs. Faul and Rizk) and the Department of Interventional Radiology (Dr. Kee), Stanford University Medical Center, Stanford CA.
Correspondence to: Norman W. Rizk, MD, FCCP, Division of Pulmonary Medicine, Stanford University Medical Center, Stanford CA 94305; e-mail: rizk{at}forsythe.stanford.edu
 |
Abstract
|
|---|
Airway complications of relapsing polychondritis (RP), including
tracheobronchial stenosis, can be fatal. This paper describes a
life-saving technique (placement of multiple metallic endobronchial
stents under conscious sedation) to prevent life-threatening airway
closure in a 50-year-old woman with RP. Using fluoroscopic and
bronchoscopic guidance, a tracheal stent and three endobronchial
metallic stents were deployed in the central airways, with good
functional outcome. There were no complications. In critical airway
compromise caused by RP, the insertion of endobronchial stents can
result in improved symptoms, pulmonary function, and a return to daily
activities, without the use of tracheotomy and mechanical
ventilation.
Key Words: bronchial relapsing polychondritis stenosis stent trachea
 |
Introduction
|
|---|
Relapsing
polychondritis (RP) is a rare multisystem disorder of unknown cause,
characterized by recurrent inflammation and destruction of cartilage.
Airway complications, including laryngeal collapse and tracheal
stenosis, occur late in the disease course and can be
fatal.1
2
Therapies for RP include high-dose
corticosteroids,2
3
cyclophosphamide, dapsone, Nd YAG
laser,4
tracheotomy, bronchial surgery, and endobronchial
stenting.4
5
Endobronchial stenting, however, may lead to
short-term loss of mucociliary clearance and acute, life-threatening
airway closure. Aspiration pneumonia, ulceration, airway erosion, and
infection are other well-recognized complications of endobronchial
stent insertion. The use of endobronchial stents, in patients with RP,
has been associated with untoward morbidity and
mortality.3
4
6
Moreover, the critical airflow limitation
of RP is not easily reversed by tracheotomy or mechanical ventilation,
inasmuch as the diffuse narrowing of the airway commonly extends along
the trachea into both mainstem bronchi and beyond.2
This
paper describes the use of multiple metallic endobronchial stents to
reverse the life-threatening airflow limitation of RP.
 |
Case Report
|
|---|
A 50-year-old woman was referred for management of a critically
narrowed airway. She was unable to speak a full sentence and could walk
< 9 m because of dyspnea. There was a 7-year history of
progressive shortness of breath and a 6-month history of severe
exercise intolerance. She reported a 5-year history of recurrent
uveitis and an 8-month history of nose deformity and collapse. For 1
year, she complained of multiple pains and exquisite tenderness,
particularly in the sternum, left ear, and ribcage. Her rheumatologic
pains, but not her dyspnea, responded to a daily dose of 10 mg of
prednisone. She was a nonsmoker, with no family history of arthritis or
asthma.
Physical examination revealed hoarseness, stridor, a "saddle"
deformity of the midnose, scleromalacia of the left eye, and a deformed
left ear. There was tenderness over all the sternocostal joints and
costal cartilages. Auscultation revealed inspiratory stridor, prolonged
expiration, and wheeze. Thoracic CT scan, with three-dimensional
reconstruction of the neck and thorax, demonstrated a diffusely
thickened tracheal wall that partly obliterated the tracheobronchial
lumen from the level of the larynx to the lobar bronchi. The maximum
diameter of the tracheal lumen, as measured by reconstruction, was 8
mm. Intraparenchymal airway size appeared to be relatively well
preserved compared with central airway narrowing (Fig 1
). Results of baseline spirometry are contained in Table 1
and Figure 2
. A diagnosis of critical airway obstruction caused by RP was made.
High-dose corticosteroids and cyclophosphamide were administered, but
without improvement in spirometry or respiratory symptoms.

View larger version (170K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1. Three-dimensional reconstruction of the patient's
thoracic CT scan. Note that the central airways (white arrow) are
severely narrowed, but the distal airway (black arrow) is relatively
well preserved.
|
|
View this table:
[in this window]
[in a new window]
|
Table 1. Results of Spirometry at Baseline, After Insertion of
Tracheal Stent, and After Insertion of Endobronchial Stents
|
|

View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2. Flow-volume loops at baseline (top,
A), after insertion of a metallic tracheal stent
(center, B), and after insertion of bilateral mainstem
and bronchus intermedius metallic stents (bottom, C).
|
|
After informed consent, and with the patient under conscious sedation
(topical lidocaine 1% applied directly to the oropharynx and larynx,
pethidine 125 mg and midazolam 4 mg IV), an endotracheal tube (size 5)
could not be passed because of the severity of tracheal narrowing. Via
the flexible bronchoscope, and using fluoroscopic guidance, a Bentson
wire was advanced into the right lower lobe bronchus. Over the wire, a
metallic Wallstent (14 x 60 mm) was deployed in the trachea
with the lower aspect of the stent extending to approximately 1 cm
above the carina. The wire was removed, and repeat bronchoscopy
confirmed the position of the stent. The patient tolerated the
procedure well and noticed an immediate improvement in her dyspnea.
Repeat spirometry demonstrated a significant improvement of airflow
(Table 1 , Fig 2
). However her FEV1 level and
FEV1/FVC ratio remained severely reduced, and she
continued to have limited exercise tolerance (walking <60 m
because of dyspnea).
Eight weeks after positioning the tracheal Wallstent, a repeat
bronchoscopy and placement of endobronchial stents were performed. The
tracheal stent was well incorporated into the tracheal wall. The
bronchus intermedius was markedly narrowed to a lumen diameter of 2 mm.
The entire left mainstem bronchus was also severely narrowed, and the
openings for the left upper and left lower lobe bronchi appeared as
slitlike orifices of 2 mm at their widest diameter. The lobar bronchi
could not be entered. Using an angled guidewire and Berenstein
catheter, the right upper lobe bronchus was selectively catheterized.
The guidewire was exchanged for a Bentson wire, and the bronchus
intermedius was selectively catheterized. A Palmaz stent (model
154; Johnson & Johnson; Warren, NJ) was deployed on an
8-mm x 2-cm-long balloon in the bronchus intermedius just below the
right upper lobe bronchus origin. A further Palmaz 154 stent loaded
onto an 8-mm x 2-cm-long balloon was deployed into the right
mainstem bronchus just above the takeoff of the right upper lobe
bronchus. The stent was subsequently dilated to 10 mm, then to 12 mm in
diameter. The left mainstem bronchus was selectively catheterized, and
a Palmaz 294 stent loaded onto an 8-mm x 3-cm-long balloon was
deployed in the left mainstem bronchus, and serially dilated to 10 mm.
Repeat bronchoscopy confirmed that the proximal portion of the stent in
the bronchus intermedius was below the takeoff of the right upper lobe
bronchus. Both of the stents within the mainstem bronchi started at the
level of the carina and extended to just above their respective upper
lobe bronchi.
The patient described a further improvement in dyspnea and a return to
normal exercise. Previously a keen golfer, she played her first round
of golf in 3 years, 2 weeks after the procedure. The results of repeat
spirometry demonstrated a significantly improved
FEV1 level and FEV1/FVC
ratio (Table 1
, Fig 2
), although they remained reduced. Repeat thoracic
CT scan with reconstruction demonstrated improved airway diameter
within the stents (Fig 3 ). On expiration, the caliber of the proximal intralobar bronchus
and the distal left mainstem bronchus narrowed to < 1 mm, whereas on
inspiration their diameter expanded to 4 mm. One year after the
procedure, the patient remains well and has normal activities of daily
living.

View larger version (131K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3. Three-dimensional reconstruction of thoracic CT
scan demonstrating tracheal stent (large white arrow), right mainstem
stent (1), left mainstem stent (2), and bronchus intermedius stent
(3).
|
|
 |
Discussion
|
|---|
This paper demonstrates that the placement of multiple metallic
bronchial stents (under conscious sedation) can successfully alleviate
critical airflow limitation caused by RP. We further report that airway
stenting in RP can result in a good patient outcome and return to
normal activities.4
6
In this patient, RP was diagnosed on
the basis of clinical features: recurrent uveitis, external otitis,
costochondritis, arthritis, and laryngotracheobronchial narrowing. In
RP, airway closure can arise for one or a combination of reasons: (1) a
localized fibrous mass may form within the airway wall, (2) the airway
can collapse because of wall destruction, and (3) (as in this case) the
airway wall can thicken because of inflammation. Diffuse narrowing of
the airway (laryngotracheobronchitis) is a well-recognized complication
of RP1
2
that can progress to life-threatening bronchial
infections and obstructive pneumonia.3
6
8
The flow-volume
loops and spirometry in this patient revealed severe expiratory airflow
limitation (Fig 2)
.8
9
The inspiratory and expiratory CT
scan reconstructions helped to demonstrate the diffuse nature of the
airway disease.
On initial presentation, we were uncertain about the contribution of
distal (small) airways to this patient's airflow limitation, because
airways > 1 mm in diameter may contain cartilage and be affected by
the cartilaginous degeneration of RP. Three-dimensional CT scan
reconstructed images (Fig 1)
suggested that fourth- and
fifth-generation airway diameters were well preserved and that airway
narrowing was most severe in the trachea and mainstem bronchi. The
dramatic improvement in airway physiology after the insertion of large
airway stents supported our theory that narrowing of the trachea and
mainstem bronchi contributed significantly to this patient's airflow
limitation.5
A greater improvement in airflow (increases
in FEV1 level and FEV1/FVC
ratio) occurred after the placement of stents in the mainstem bronchi
and bronchus intermedius than after the placement of the tracheal
stent.
Our limited experience with critical airway compromise in RP suggests
that significant improvements in airflow limitation may occur after the
placement of metallic endobronchial stents in the trachea and mainstem
bronchi. Placement of endobronchial stents at the main points of
airflow obstruction can help to avoid tracheotomy and mechanical
ventilation, and may lead to improved patient functionality and
survival.
 |
Footnotes
|
|---|
Abbreviation: RP = relapsing polychondritis
Received for publication March 30, 1999.
Accepted for publication April 18, 1999.
 |
References
|
|---|
-
Carrion, M, Giron, JA, Ventura, J, et al (1993) Airway complications in relapsing polychondritis. J Rheumatol 20,1628-1629[Medline]
-
Eng, J, Sabanathan, S (1991) Airway complications in relapsing polychondritis. Ann Thorac Surg 51,686-692[Abstract]
-
Sane, DC, Vidaillet, HJ, Jr, Burton, CS, 3d (1987) Saddle nose, red ears, and fatal airway collapse: relapsing polychondritis. Chest 91,268-270[Free Full Text]
-
Sacco, O, Fregonese, B, Oddone, M, et al (1997) Severe endobronchial obstruction in a girl with relapsing polychondritis: treatment with Nd YAG laser and endobronchial silicon stent. Eur Respir J 10,494-496[Abstract]
-
Lehman, JD, Gordon, RL, Kerlan, RK, Jr, et al (1998) Expandable metallic stents in benign tracheobronchial obstruction. J Thorac Imaging 13,105-115[ISI][Medline]
-
Dunne, JA, Sabanathan, S (1994) Use of metallic stents in relapsing polychondritis. Chest 105,864-867[Abstract/Free Full Text]
-
Wallace, MJ, Charnsangavej, C, Ogawa, K, et al (1986) Tracheobronchial tree: expandable metallic stents used in experimental and clinical applications. Radiology 158,309-312[Abstract/Free Full Text]
-
Krell, WS, Staats, BA, Hyatt, RE (1986) Pulmonary function in relapsing polychondritis. Am Rev Respir Dis 133,1120-1123[ISI][Medline]
-
Mohsenifar, Z, Tashkin, DP, Carson, SA, et al (1982) Pulmonary function in patients with relapsing polychondritis. Chest 81,711-717[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
N. Maimon, T. Marras, D. Hwang, N. Paul, S. Keshavjee, and C. K. N. Chan
A 46-year-old female with dyspnoea, stridor and chronic cough.
Eur. Respir. J.,
September 1, 2006;
28(3):
666 - 669.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lee, A. Ernst, D. E. Trentham, W. Lunn, D. J. Feller-Kopman, and P. M. Boiselle
Relapsing Polychondritis: Prevalence of Expiratory CT Airway Abnormalities
Radiology,
August 1, 2006;
240(2):
565 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Thornton, R. L. Gordon, R. K. Kerlan, J. M. LaBerge, M. W. Wilson, K. A. Wolanske, M. B. Gotway, G. S. Hastings, and J. A. Golden
Outcomes of tracheobronchial stent placement for benign disease.
Radiology,
July 1, 2006;
240(1):
273 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Behar, Y.-W. Choi, T. A. Hartman, N. B. Allen, and H. P. McAdams
Relapsing Polychondritis Affecting the Lower Respiratory Tract
Am. J. Roentgenol.,
January 1, 2002;
178(1):
173 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|